Postsynaptic Α -2 Adrenergic Receptors Are Critical for the Antidepressant-Like Effects of Desipramine on Behavior
Han-Ting Zhang,Lisa R Whisler,Ying Huang,Yang Xiang,James M O'Donnell
DOI: https://doi.org/10.1038/npp.2008.184
2008-01-01
Neuropsychopharmacology
Abstract:The antidepressant desipramine inhibits the reuptake of norepinephrine (NE), leading to activation of both pre- and postsynaptic adrenergic receptors, including α -1, α -2, β -1, and β -2 subtypes. However, it is not clear which adrenergic receptors are involved in mediating its antidepressant effects. Treatment of mice with desipramine (20 mg/kg, i.p.) produced an antidepressant-like effect, as evidenced by decreased immobility in the forced-swim test; this was antagonized by pretreatment with the α -2 adrenergic antagonist idazoxan (0.1–2.5 mg/kg, i.p.). Similarly, idazoxan, administered peripherally (0.5–2.5 mg/kg, i.p.) or centrally (1–10 μg, i.c.v.), antagonized the antidepressant-like effect of desipramine in rats responding under a differential-reinforcement-of-low-rate (DRL) 72-s schedule, ie, decreased response rate and increased reinforcement rate. By contrast, pretreatment with the β -adrenergic antagonists propranolol and CGP-12177 or the α -1 adrenergic antagonist prazosin did not alter the antidepressant-like effect of desipramine on DRL behavior. The lack of involvement of β -adrenergic receptors in mediating the behavioral effects of desipramine was confirmed using knockout lines. In the forced-swim test, the desipramine-induced decrease in immobility was not altered in mice deficient in β -1, β -2, or both β -1 and β -2 adrenergic receptors. In addition, desipramine (3–30 mg/kg) produced an antidepressant-like effect on behavior under a DRL 36-s schedule in mice deficient in both β -1 and β -2 adrenergic receptors. As antagonism of presynaptic α -2 adrenergic receptors facilitates NE release, which potentiates the effects of desipramine, the present results suggest that postsynaptic α -2 adrenergic receptors play an important role in its antidepressant effects.